Launching in 2015, Cell & Gene Therapy Europe offers a brand new knowledge exchange, benchmarking and networking opportunity for the global sector.

What’s Different from Phacilitate Washington?

Specific European content focus
–    Agenda focuses specifically on ‘Euro-centric’ topics, issues and opportunities: from detailed analysis of European regulatory pathways, to troubleshooting clinical development on the continent, to clarification of funding availability/access on a nation-by-nation basis.

Attendee profile
–    80%+ of attendees in Barcelona will hail from Europe.

See more here